Expert consensus on acute exacerbation of chronic obstructive pulmonary disease in the People's Republic of China

International Journal of COPD

Volumn 9, Issue , 2014, Pages 381-395

  Cai, Bai Qiang ^a   Cai, Shao Xi ^b   Chen, Rong Chang ^c   Cui, Li Ying ^d   Feng, Yu Lin ^e   Gu, Yu Tong ^f   Huang, Shao Guang ^g   Liu, Rong Yu ^h   Liu, Guang Nan ⁱ   Shi, Huan Zhong ^j   Shi, Yi ^k   Song, Yuan Lin ^f   Sun, Tie Ying ^l   Wang, Chang Zheng ^m   Wang, Jing Lan ^a   Wen, Fu Qiang ^e   Xiao, Wei ⁿ   Xu, Yong Jian ^o   Yan, Xi Xin ^p   Yao, Wan Zhen ^q   Yu, Qin ^r   Zhang, Jing ^f   Zheng, Jin Ping ^c   Liu, Jie ^f   Bai, Chun Xue ^f   more..

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b FIRST MILITARY MEDICAL UNIVERSITY   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

^d Affiliate Hospital of Inner Mongolia Medical University   (China)

^e SICHUAN UNIVERSITY   (China)

^f FUDAN UNIVERSITY   (China)

^g SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^h ANHUI MEDICAL UNIVERSITY   (China)

ⁱ GUANGXI UNIVERSITY   (China)

^j CAPITAL MEDICAL UNIVERSITY   (China)

^k NANJING GENERAL HOSPITAL OF NANJING MILITARY COMMAND   (China)

^l BEIJING HOSPITAL   (China)

^m THIRD MILITARY MEDICAL UNIVERSITY   (China)

ⁿ SHANDONG UNIVERSITY   (China)

^o HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^p HEBEI MEDICAL UNIVERSITY   (China)

^q PEKING UNIVERSITY THIRD HOSPITAL   (China)

^r LANZHOU UNIVERSITY   (China)

more..

Author keywords

AECOPD; COPD; Guidelines; Recommendations

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIVIRUS AGENT; BRONCHODILATING AGENT; CARDIOTONIC AGENT; CORTICOSTEROID; DIURETIC AGENT; RESPIRATORY STIMULANT AGENT; THEOPHYLLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; BIOCHEMISTRY; BLOOD GAS ANALYSIS; CHINA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG CHOICE; DRUG EFFECT; DRUG INDICATION; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ENVIRONMENTAL FACTOR; FOLLOW UP; HEART ARRHYTHMIA; HEART FAILURE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INFLUENZA; INTENSIVE CARE UNIT; LABORATORY TEST; LOW DRUG DOSE; LUNG EMBOLISM; LUNG FUNCTION; MAXIMUM PLASMA CONCENTRATION; MECHANICAL VENTILATOR; MOLECULAR PATHOLOGY; NONHUMAN; OUTCOME ASSESSMENT; OXYGEN THERAPY; PALLIATIVE THERAPY; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PROFESSIONAL COMPETENCE; PROFESSIONAL KNOWLEDGE; PULMONOLOGIST; QUALITY OF LIFE; SPIROMETRY; SPUTUM CULTURE; TERMINAL CARE; THORAX RADIOGRAPHY; VIRUS INFECTION;

AECOPD; COPD; GUIDELINES; RECOMMENDATIONS;

CHINA; CONSENSUS; DISEASE PROGRESSION; HUMANS; LUNG; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY MEDICINE; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84899658193     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S58454     Document Type: Article

References (41)

1. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347-365.
2. Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med. 2007;176(8):753-760.
3. Perera PN, Armstrong EP, Sherrill DL, Skrepnek GH. Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality. COPD. 2012;9(2):131-141.
4. Chen YH, Yao WZ, Cai BQ, et al. Economic analysis in admitted patients with acute exacerbation of chronic obstructive pulmonary disease. Chin Med J (Engl). 2008;121(7):587-591.
5. Zhu M, Cai B. Costs of the last hospitalization for patients with acute exacerbation of chronic obstructive pulmonary disease and patients with lung cancer. Chin J Tuberc Respir Dis. 2009;32(4):258-261.
6. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6):932-946.
7. Mackay AJ, Hurst JR. COPD exacerbations: causes, prevention, and treatment. Med Clin North Am. 2012;96(4):789-809.
8. Molyneaux PL, Mallial P, Coxl MJ, et al. Outgrowth of the bacterial airway microbiome after rhinovirus eacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;188(10): 1224-1231.
9. Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections - summary. Clin Microbiol Infect. 2011;17 Suppl 6:1-24.
10. Chen M, Liu T, Cai B. Interpretation of guidelines for the management of adult lower respiratory tract infections - summary. Int J Respir. 2012;32(16):1201-1206.
11. Chinese Expert Panel on Antibiotics Therapy in Acute Exacerbation of Chronic Obstructive Pulmonary Diseases. The role of antibiotics therapy in guideline for diagnosis and management of chronic obstructive pulmonary diseases. Chin J Tuberc Respir Dis. 2013;36(9):712-714.
12. Ye F, He L, Cai B, et al. Spectrum and antimicrobial resistance of common pathogenic bacteria isolated from patients with acute exacerbation of chronic obstructive pulmonary disease in mainland of China. Chin Med J (Engl). 2013;126(12):2207-2214.
13. Chinese Chronic Obstructive Pulmonary Diseases Study Group, Chinese Society of Respiratory Diseases. Guideline for diagnosis and management of chronic obstructive pulmonary diseases in China (Revised 2013). Chin J Tuberc Respir Dis. 2013;36(4):255-264.
14. Koutsokera A, Stolz D, Loukides S, Kostikas K. Systemic biomarkers in exacerbations of COPD: the evolving clinical challenge. Chest. 2012;141(2):396-405.
15. Bertoletti L, Quenet S, Mismetti P, et al. Clinical presentation and outcome of venous thromboembolism in COPD. Eur Respir J. 2012;39(4): 862-868.
16. Yu S. Inhalation therapy of chronic obstructive pulmonary diseases and bronchial asthma. Chin J Drug App Monitor. 2006;3(4):28-31.
17. Chinese Expert Panel on Inhalation Therapy in Adult Chronic Airway Diseases. Expert consensus on inhalation therapy in adult chronic airway diseases. Chin J Respir Crit Care Med. 2012;11(2):105-110.
18. Leuppi JD, Schuetz P, Bingisser R, et al. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA. 2013;309(21):2223-2231.
19. Miravitlles M, Anzueto A. Antibiotics for acute and chronic respiratory infection in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;188(9):1052-1057.
20. Mackay AJ, Hurst JR. COPD exacerbations: causes, prevention, and treatment. Med Clin North Am. 2012;96(4):789-809.
21. Mallia P, Singanayagam A, Johnston SL. Virus-bacteria interactions in COPD exacerbations. Eur Respir Monogr. 2013;60:76-83.
22. Chinese Society of Critical Care Medicine. Guideline for mechanical ventilation in patients with acute exacerbation of chronic obstructive pulmonary disease (2007). Chin Crit Care Med. 2007;19(9):513-518.
23. Qin C, Chen R, Zhong N. The physiological impact of and clinical strategy for PEEPi in chronic obstructive pulmonary disease. Chin J Respir Crit Care Med. 2004;3(2):126-128.
24. Luo Q, Chen R. Analysis on treatment compliance of patients with acute exacerbations of chronic obstructive pulmonary disease on non-invasive positive pressure ventilation. Guangdong Medical Journal. 2012;33(9):1310-1312. [Chinese.]
25. British Thoracic Society Standards of Care Committee. Non-invasive ventilation in acute respiratory failure. Thorax. 2002;57(3):192-211.
26. Wang C, Shang M, Huang K. Sequential non-invasive following short-term invasive mechanical ventilation in COPD induced hypercapnic respiratory failure. Chin J Tuberc Respir Dis. 2000;23(4):212.
27. Chinese Respiratory Physiology and Intensive Care Study Group, Editorial Committee of Chinese Journal of Tuberculosis and Respiratory Diseases. Expert consensus on non-invasive positive pressure ventilation. Chin J Tuberc Respir Dis. 2009;32(2):86-98.
28. Wise AL. Chronic obstructive lung disease: clinical course and management. In: Fishman AP, editor. Fishman's Pulmonary Diseases and Disorders. 4th ed. New York: McGraw-Hill. 2008;729-746.
29. Albert P, Calverley PM. Drugs (including oxygen) in severe COPD. Eur Respir J. 2008;31(5):1114-1124.
30. Ban A, Ismail A, Harun R, et al. Impact of clinical pathway on clinical outcomes in the management of COPD Exacerbation. BMC Pulm Med. 2012;12:27-42.
31. Rizkallah J, Man SF, Sin DD. Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and meta-analysis. Chest. 2009;135(3):786-793.
32. Li X, Wang C, Yang Y. Advances in acute exacerbations of chronic obstructive pulmonary disease complicated with venous thromboembolism. Chinese Journal for Clinicians. 2008;36(7): 26-28. [Chinese.]
33. Chinese Society of Respiratory Diseases. Guidelines for diagnosis and treatment of pulmonary thromboembolism. Chin J Tuberc Respir Dis. 2001;24(5):259-264.
34. Chinese Pulmonary Vascular Diseases Study Group, Cardiovascular Physician Branch. Experts Consensus on Acute Pulmonary Thromboembolism in China. Chin J Intern Med. 2010;49(1):74-81.
35. Brulotte CA, Lang ES. Acute exacerbations of chronic obstructive pulmonary disease in the emergency department. Emerg Med Clin North Am. 2012;30(2):223-247.
36. Liu T, Cai B. Introduction of global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (Revised 2013). Chin J Tuberc Respir Dis. 2013;36(11):805-807.
37. Han MK, Martinez FJ. Pharmacotherapeutic approaches to preventing acute exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2011;8(4):356-362.
38. Zheng JP, Kang J, Huang SG, et al. Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study. Lancet. 2008;371(9629): 2013-2018.
39. Llor C, Moragas A, Hernandez S, Bayona C, Miravitlles M. Efficacy of antibiotic therapy for acute exacerbations of mild to moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(8):716-723.
40. McLean S, Nurmatov U, Liu JL, et al. Telehealthcare for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011(7):CD007718.
41. Yohannes AM. Telehealthcare management for patients with chronic obstructive pulmonary disease. Expert Rev Respir Med. 2012;6(3): 239-242.